Sentence examples for biologic evaluation from inspiring English sources

Here, we report the synthesis and biologic evaluation of novel naphthoquinone derivatives as selective small molecule inhibitors of PKM2.

Jones GS, Livni E, Strauss HW, Hanson RN, Elmaleh DR. Synthesis and biologic evaluation of 1-[11C]-3,3-dimethylheptadecanoic 1-[11C]-3,3-dimethylheptadecanoic 1-[11C]-3,3-dimethylheptadecanoic 1-[11C]-3,3-dimethylheptadecanoic

"Gastric Intestinal Metaplasia with Basal Gland Atypia: a Morphological and Biologic Evaluation in a Large Chinese Cohort". Human Pathology 44 (4) (April): 578 590.

In this work, we report the design, synthesis, and biologic evaluation of a novel series of galloyl derivatives with HIV-1 RNase H inhibitory activity.

Design, synthesis, and biologic evaluation of novel galloyl derivatives as HIV-1 RNase H inhibitors. LncRNAs-directed PTEN enzymatic switch governs epithelial-mesenchymal transition.

In practice, however, ED physicians must base their biologic evaluation on a single blood sample and not on sequential samples.

Further studies should include molecular biologic evaluations, so that genetic and epigenetic modifications could be related to changes of the fractal characteristics.

Because the new blood tests are experimental, it is not clear how much virus must be present before West Nile can be detected, so the tests "may not be 100percentt effective in keeping infected blood out of the system," said Dr. Jesse Goodman, director of the Food and Drug Administration's Center of Biologics Evaluation and Research.

Dr. Peter Marks, director of the F.D.A.'s center for biologics evaluation and research, said that the agency would continue to pursue unscrupulous clinics, but that those performing orthopedic procedures — injecting the fat-derived cells into joints — would take a back seat to clinics that inject or infuse cells into the central nervous system or bloodstream.

Although P. hydropiper is widely used an ethnomedicinal plant and deep-drawing phytochemical analysis were conveyed out on it biologics evaluation of P. hydropiper.

- The oncolytic polio-rhinovirus recombinant (PVSRIPO) has demonstrated promise in currently ongoing phase I/II clinical trials against recurrent glioblastoma and was granted breakthrough therapy designation by the Food and Drug Administration/Center for Biologics Evaluation and Research.